Skip to content

Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer Patients

PRO-COM Project: Randomized-controlled Study Evaluating the Impact of Electronic Patient Reported Outcome (ePRO) Surveys on Patient-physician Communication and Quality of Life in Patients With Advanced Breast Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03525990
Enrollment
62
Registered
2018-05-16
Start date
2018-01-10
Completion date
2022-04-30
Last updated
2023-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasm Malignant Female

Brief summary

PRO-COM Project: Randomized-controlled study evaluating the impact of electronic patient reported outcome (ePRO) surveys on patient-physician communication and quality of life in patients with advanced breast cancer

Interventions

OTHERQuestionnaires

Quality of life questionnaires on iPads with CHES (Computer-based Health Evaluation System), paper-based questionnaire (EORTC QLQ-COMU26)

Sponsors

Dr. Vera Trommet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Stage IV breast cancer * Start of a systemic anti cancer therapy: chemotherapy -/+ antibody therapy 1st until 3rd line (palliative), endocrine therapy or other therapy without limit * Estimated life expectancy of minimum six months * Signed informed consent * No cognitive or speech impairments

Design outcomes

Primary

MeasureTime frameDescription
Patient-physician communicationUp to six monthsThe communication between patient and physician will be assessed with EORTC QLQ-COMU26. Presumably some patients have privacy concerns with electronic questionnaires. The EORTC-COMU26 is the most important questionnaire in this study because it is needed for the primary endpoint. It contains sensitive questions about how the patient experiences the communication during the visit. In order to avoid patients not filling out the questionnaire due to privacy concerns or being afraid of giving an honest opinion and the physician could read it electronically, the EORTC QLQ-COMU26 is paper-based and the patients can hand them in in the study office.

Secondary

MeasureTime frameDescription
Quality of life assessmentArm A: at every visit for six months; Arm B: at baseline, three months, six monthsQuality of life will be assessed electronically with EORTC QLQ-C30.
Frequency of discontinuations of therapyUp to six monthsThe frequency of discontinuations will be assessed based on medical reports.
Duration of communication between physician and patientAt baseline, three months, six months in both groupsPhysicians call the study office at the beginning and at the end of the consultation at baseline, three months and six months. They will record the duration of the consultation.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026